HRC calls on Turing CEO to lower price on HIV drug
WASHINGTON – Today, the Human Rights Campaign (HRC) once again called on Turing Pharmaceuticals CEO Martin Shkreli to make good on his unfulfilled promise of Sept. 22 to lower the price on Daraprim — a crucial and often lifesaving treatment for those living with HIV — and urged officials to expeditiously investigate Turing’s reckless overnight 5,000…